EXECUTIVE Trial Supports Abbott Vascular's Xience V EES in Treatment of Multivessel CAD
September 18, 2013—Flavio Ribichini, MD, et al have published results from the EXECUTIVE trial, a clinical and angiographic study of the Xience V everolimus-eluting coronary stent system (Abbott Vascular, Santa Clara, CA) in the treatment of patients with multivessel coronary artery disease.
